184 related articles for article (PubMed ID: 31565883)
41. Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
Asari Y; Kageyama K; Sugiyama A; Kogawa H; Niioka K; Daimon M
Endocr J; 2019 Jun; 66(6):515-522. PubMed ID: 30880293
[TBL] [Abstract][Full Text] [Related]
42. A human ACTH-secreting corticotroph tumoroid model: Novel Human ACTH-Secreting Tumor Cell in vitro Model.
Zhang D; Hugo W; Redublo P; Miao H; Bergsneider M; Wang MB; Kim W; Yong WH; Heaney AP
EBioMedicine; 2021 Apr; 66():103294. PubMed ID: 33773184
[TBL] [Abstract][Full Text] [Related]
43. Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas.
Fernando MA; Heaney AP
Mol Endocrinol; 2005 Dec; 19(12):3085-96. PubMed ID: 16020484
[TBL] [Abstract][Full Text] [Related]
44. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.
Tateno T; Izumiyama H; Doi M; Akashi T; Ohno K; Hirata Y
Endocr J; 2007 Dec; 54(5):777-82. PubMed ID: 17917309
[TBL] [Abstract][Full Text] [Related]
45. Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas.
Hashimoto K; Matsumoto S; Ishida E; Miura A; Horiguchi K; Ozawa A; Shibusawa N; Satoh T; Yamada M; Yamada S; Mori M
Neurosci Lett; 2011 Apr; 494(1):34-7. PubMed ID: 21356276
[TBL] [Abstract][Full Text] [Related]
46. Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas.
Ishino H; Hara Y; Takekoshi S; Teshima T; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2011 Nov; 41(4):207-13. PubMed ID: 21982272
[TBL] [Abstract][Full Text] [Related]
47. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
48. Effects of oxytocin on prosocial behavior and the associated profiles of oxytocinergic and corticotropin-releasing hormone receptors in a rodent model of posttraumatic stress disorder.
Wang SC; Lin CC; Tzeng NS; Tung CS; Liu YP
J Biomed Sci; 2019 Mar; 26(1):26. PubMed ID: 30898126
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells.
Asari Y; Kageyama K; Nakada Y; Tasso M; Takayasu S; Niioka K; Ishigame N; Daimon M
Onco Targets Ther; 2017; 10():4329-4338. PubMed ID: 28919782
[TBL] [Abstract][Full Text] [Related]
50. O-GlcNAcylation Is Essential for Rapid Pomc Expression and Cell Proliferation in Corticotropic Tumor Cells.
Massman LJ; Pereckas M; Zwagerman NT; Olivier-Van Stichelen S
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34418053
[TBL] [Abstract][Full Text] [Related]
51. HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas.
Evang JA; Borota OC; Melum E; Holm R; Ramm-Pettersen J; Bollerslev J; Berg JP
Clin Endocrinol (Oxf); 2010 Aug; 73(2):229-35. PubMed ID: 20346000
[TBL] [Abstract][Full Text] [Related]
52. [Pathology and pathogenesis of pituitary corticotroph adenoma].
Trouillas J
Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
[TBL] [Abstract][Full Text] [Related]
54. Oxytocin is involved in steroid hormone-stimulated bovine satellite cell proliferation and differentiation in vitro.
Zhang Z; Zhao LD; Johnson SE; Rhoads ML; Jiang H; Rhoads RP
Domest Anim Endocrinol; 2019 Jan; 66():1-13. PubMed ID: 30195176
[TBL] [Abstract][Full Text] [Related]
55. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
56. Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression.
Saito-Hakoda A; Uruno A; Yokoyama A; Shimizu K; Parvin R; Kudo M; Saito-Ito T; Sato I; Kogure N; Suzuki D; Shimada H; Yoshikawa T; Fujiwara I; Kagechika H; Iwasaki Y; Kure S; Ito S; Sugawara A
PLoS One; 2015; 10(12):e0141960. PubMed ID: 26714014
[TBL] [Abstract][Full Text] [Related]
57. Molecular Biology of Pituitary Adenomas.
Faltermeier CM; Magill ST; Blevins LS; Aghi MK
Neurosurg Clin N Am; 2019 Oct; 30(4):391-400. PubMed ID: 31471046
[TBL] [Abstract][Full Text] [Related]
58. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
59. Lipopolysaccharide stimulates proopiomelanocortin gene expression in AtT20 corticotroph cells.
Iwasaki Y; Taguchi T; Nishiyama M; Asai M; Yoshida M; Kambayashi M; Takao T; Hashimoto K
Endocr J; 2008 May; 55(2):285-90. PubMed ID: 18323674
[TBL] [Abstract][Full Text] [Related]
60. Bone morphogenetic protein 4 and bone morphogenetic protein receptor expression in the pituitary gland of adult dogs in healthy condition and with ACTH-secreting pituitary adenoma.
Sato A; Ochi H; Harada Y; Yogo T; Kanno N; Hara Y
Domest Anim Endocrinol; 2017 Jan; 58():126-133. PubMed ID: 26542941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
